InMed Pharmaceuticals Inc.
INM
$1.47
-$0.06-3.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.20M | 7.00M | 9.37M | 11.12M | 4.72M |
| Total Receivables | -- | 183.00K | 343.50K | 465.10K | 367.80K |
| Inventory | -- | 947.90K | 890.80K | 961.20K | 814.00K |
| Prepaid Expenses | 617.20K | 660.30K | 191.80K | 321.70K | 507.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.07M | -- | -- | -- | -- |
| Total Current Assets | 6.89M | 8.79M | 10.80M | 12.87M | 6.41M |
|
|
|||||
| Total Current Assets | 6.89M | 8.79M | 10.80M | 12.87M | 6.41M |
| Net Property, Plant & Equipment | 642.90K | 764.30K | 881.50K | 992.20K | 1.11M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.50M | 1.54M | 1.58M | 1.62M | 1.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 104.40K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Assets | 9.13M | 11.19M | 13.36M | 15.58M | 9.28M |
|
|
|||||
| Total Accounts Payable | 225.10K | 166.80K | 369.10K | 370.10K | 559.80K |
| Total Accrued Expenses | 786.50K | 697.70K | 592.30K | 1.03M | 846.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 389.40K | 408.10K | 424.80K | 435.50K | 429.20K |
| Total Finance Division Other Current Liabilities | 810.30K | 207.40K | 168.80K | 700.00 | 3.70K |
| Total Other Current Liabilities | 810.30K | 207.40K | 168.80K | 700.00 | 3.70K |
| Total Current Liabilities | 2.21M | 1.48M | 1.56M | 1.84M | 1.84M |
|
|
|||||
| Total Current Liabilities | 2.21M | 1.48M | 1.56M | 1.84M | 1.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.80K | 123.80K | 215.50K | 305.80K | 419.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.24M | 1.60M | 1.77M | 2.15M | 2.26M |
|
|
|||||
| Common Stock & APIC | 130.72M | 130.45M | 130.43M | 130.54M | 122.34M |
| Retained Earnings | -123.96M | -120.99M | -118.96M | -117.24M | -115.45M |
| Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
| Total Common Equity | 6.89M | 9.59M | 11.59M | 13.43M | 7.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.89M | 9.59M | 11.59M | 13.43M | 7.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.89M | 9.59M | 11.59M | 13.43M | 7.02M |
|
|
|||||